WhiteOak Capital Pharma and Heathcare Fund

    +26.8%1Y

    NAV ₹18.45 · 20 Nov

    NAV by date
    DateNAV
    19 Nov 2025₹14.54
    4 Dec 2025₹14.51
    18 Dec 2025₹14.12
    5 Jan 2026₹14.34
    21 Jan 2026₹13.52
    6 Feb 2026₹13.74
    20 Feb 2026₹14.19
    10 Mar 2026₹14.40
    25 Mar 2026₹14.23
    13 Apr 2026₹14.16
    28 Apr 2026₹14.71
    14 May 2026₹15.60
    2 Jun 2026₹15.46
    17 Jun 2026₹15.81
    2 Jul 2026₹16.74
    17 Jul 2026₹16.80
    3 Aug 2026₹17.30
    18 Aug 2026₹17.58
    1 Sept 2026₹17.67
    17 Sept 2026₹17.61
    5 Oct 2026₹17.07
    21 Oct 2026₹16.35
    4 Nov 2026₹17.71
    20 Nov 2026₹18.45

    An open-ended sectoral fund from WhiteOak Capital Mutual Fund. Direct plan since February 2024. Figures for the Direct plan, Growth option.

    Fund size
    ₹964 Cr
    Category median ₹569 Cr
    Expense ratio
    1.07%
    Category 1.01%
    1Y return
    26.8%
    Category 4.9%
    Deepest fall, whole history
    −15.4%
    Now −0.0%
    Top 10 holdings
    46.9%
    65 holdings

    Returns against the category

    PeriodThis fundFundCategory medianCategory
    1 month1M12.0%10.0%
    3 months3M5.3%2.3%
    6 months6M17.1%10.3%
    1 year1Y26.8%4.9%
    3 years (a year)3Y–14.6%
    5 years (a year)5Y–14.3%
    10 years (a year)10Y–16.5%
    Since February 2024 (a year)Launch24.6%12.7%
    Returns up to 20 Nov 2026. Up to a year: absolute; longer: a year (CAGR).

    Ups and downs

    0.0%below its previous high

    Now · deepest ever −15.4% · chart from February 2024

    Fall from the previous high, by date
    DateBelow peak
    6 Feb 20240.0%
    20 Mar 2024−6.0%
    7 May 2024−2.2%
    20 Jun 2024−0.7%
    1 Aug 20240.0%
    13 Sept 20240.0%
    28 Oct 2024−3.5%
    12 Dec 2024−0.6%
    24 Jan 2025−6.8%
    10 Mar 2025−12.9%
    25 Apr 2025−7.4%
    9 Jun 2025−4.2%
    18 Jul 2025−0.5%
    2 Sept 2025−3.3%
    15 Oct 2025−1.8%
    1 Dec 2025−1.0%
    13 Jan 2026−3.7%
    26 Feb 2026−0.8%
    15 Apr 2026−2.5%
    1 Jun 2026−2.0%
    13 Jul 2026−0.2%
    24 Aug 2026−1.4%
    7 Oct 2026−4.1%
    20 Nov 20260.0%
    Volatility (3Y)
    –standard deviation, a year
    Deepest fall
    −15.4%from a peak, whole history

    What it holds

    Portfolio as disclosed for October 2026: 65 holdings, the ten largest 46.9% of the fund.

    Asset mix
    • Equity90.7%
    • Debt4.1%
    • Cash and equivalents5.3%
    By company size
    • Large cap27.3%
    • Mid cap24.4%
    • Small cap35.3%
    Sectors
    • Health Care84.7%
    • Others9.4%
    • Materials4.6%
    • Industrials1.4%

    Largest holdings

    1. Divi's Laboratories LimitedPharmaceuticals & Biotechnology8.87%
    2. Sun Pharmaceutical Industries LimitedPharmaceuticals & Biotechnology6.68%
    3. Torrent Pharmaceuticals LimitedPharmaceuticals & Biotechnology5.87%
    4. Laurus Labs LimitedPharmaceuticals & Biotechnology5.59%
    5. Clearing Corporation of India Ltd4.62%
    6. Apollo Hospitals Enterprise LimitedHealthcare Services3.73%
    7. Zydus Lifesciences LimitedPharmaceuticals & Biotechnology3.10%
    8. Sai Life Sciences LimitedPharmaceuticals & Biotechnology3.02%
    9. IPCA Laboratories LimitedPharmaceuticals & Biotechnology2.91%
    10. Mankind Pharma LimitedPharmaceuticals & Biotechnology2.50%

    Fund size over time

    ₹964 CrOctober 2026

    From ₹443 Cr in September 2025; all plans together

    Fund size by month end
    Month endFund size
    30 Sept 2025₹443 Cr
    31 Oct 2025₹480 Cr
    30 Nov 2025₹502 Cr
    31 Dec 2025₹509 Cr
    31 Jan 2026₹492 Cr
    28 Feb 2026₹533 Cr
    31 Mar 2026₹556 Cr
    30 Apr 2026₹603 Cr
    31 May 2026₹664 Cr
    30 Jun 2026₹741 Cr
    31 Jul 2026₹825 Cr
    31 Aug 2026₹902 Cr
    30 Sept 2026₹927 Cr
    31 Oct 2026₹964 Cr

    Key facts

    Plan and option
    Direct plan, Growth option
    Launched
    6 Feb 2024
    Benchmark
    BSE Health Care - TRI
    Fund managers
    Ramesh Mantri, Piyush Baranwal, Dheeresh Pathak, Ashish Agrawal
    Exit load
    Nil
    Minimum investment
    SIP ₹100 a month · one-time ₹500
    ISIN
    INF03VN01886

    Other Sectoral funds

    The largest other funds in the category by fund size, not a ranking. All Sectoral funds · Compare side by side

    Questions about WhiteOak Capital Pharma and Heathcare Fund

    What is the expense ratio of WhiteOak Capital Pharma and Heathcare Fund?

    The Direct plan's expense ratio is 1.07% a year as of 31 Oct 2026. It is taken out of the fund's assets every day, so the NAV and the returns shown are already after it.

    How large is WhiteOak Capital Pharma and Heathcare Fund?

    WhiteOak Capital Pharma and Heathcare Fund manages ₹964 Cr as of 31 Oct 2026.

    What returns has WhiteOak Capital Pharma and Heathcare Fund given?

    1 year: 26.8% (category median 4.9%). Figures are for the Direct plan, Growth option, up to 20 Nov 2026. Past returns do not guarantee future returns.

    How much does WhiteOak Capital Pharma and Heathcare Fund go up and down?

    Its largest fall from a peak over its whole history was 15.4%.

    What is the benchmark of WhiteOak Capital Pharma and Heathcare Fund?

    The fund measures itself against the BSE Health Care - TRI.

    Who manages WhiteOak Capital Pharma and Heathcare Fund?

    Ramesh Mantri, Piyush Baranwal, Dheeresh Pathak and Ashish Agrawal manage the fund.

    Is there an exit load on WhiteOak Capital Pharma and Heathcare Fund?

    Exit load: Nil.

    What is the minimum investment in WhiteOak Capital Pharma and Heathcare Fund?

    A SIP can start from ₹100 a month. A one-time investment can start from ₹500.

    About the fund house, WhiteOak Capital Mutual Fund

    WhiteOak Capital Mutual Fund runs 23 funds on this site, managing ₹48,232 Cr together.

    See every WhiteOak Capital Mutual Fund fund